DRUG
MECHANISM
USES
TOXICITY · NOTES
Binds ergosterol → pores → K⁺/Mg²⁺ leak
Severe systemic mycoses, cryptococcal meningitis, mucormycosis, visceral leishmaniasis
Nephrotoxicity, hypokalemia, hypomagnesemia, infusion fever/chills, arrhythmias · saline loading, liposomal formulation
Polyene, too toxic for IV
Oral thrush (swish), cutaneous/vaginal Candida
Not absorbed
Azole: inhibits 14α-demethylase (lanosterol → ergosterol)
Candida (mucosal, vaginal, many invasive), cryptococcal maintenance, coccidioidomycosis
Good CSF/urine levels · no mold coverage · C krusei resistant
Azole
Histoplasma, Blastomyces, Sporothrix, Paracoccidioides; ABPA; onychomycosis
Negative inotrope — avoid in heart failure
Azole, broad
Invasive aspergillosis (drug of choice)
Visual changes, photosensitivity → skin cancer, hallucinations, periostitis (fluoride)
Posaconazole · isavuconazole
Azole, broadest
Mucormycosis (step-down), prophylaxis in leukemia/transplant
Isavuconazole shortens QT
Ketoconazole · clotrimazole · miconazole
Azole, mostly topical
Tinea, seborrheic dermatitis, Candida skin and vaginal infections
Oral ketoconazole blocks steroid synthesis → gynecomastia, ↓ libido; hepatotoxic
Inhibit human CYP3A4 too
—
↑ levels of tacrolimus, cyclosporine, warfarin, statins · hepatotoxicity, QT
Inhibit β-1,3-D-glucan synthase → wall
Candidemia (first-line), esophageal candidiasis, refractory aspergillosis
IV only · histamine flushing · no Cryptococcus or Mucor activity
Converted to 5-FU by fungal cytosine deaminase → blocks DNA/RNA
Cryptococcal meningitis with amphotericin
Bone marrow suppression · never alone (resistance)
Inhibits squalene epoxidase → squalene accumulates
Onychomycosis, tinea capitis, tinea pedis
Hepatotoxicity, taste disturbance
Binds microtubules → blocks mitosis; deposits in keratin
Tinea capitis
CYP450 inducer (↓ warfarin, OCPs), teratogen, disulfiram-like reaction, photosensitivity